BLUE - bluebird bio, Inc.

QQQ $ 479.76 $ 5.15 (1.08 %)

DIA $ 411.97 $ 4.35 (1.07 %)

SPY $ 562.00 $ 5.91 (1.06 %)

TLT $ 98.37 $ 0.64 (0.65 %)

GLD $ 231.99 $ 2.65 (1.16 %)

Previous Close

$ 0.6887

Open

Bid

$ 0.69 x 600

Ask

$ 0.71 x 882

Day's Range

-- - --

52 Week Range

$ 0.65 - $ 5.53

Volume

4,788,314

Average Volume

Market Cap

75.3M

Beta (5Y Monthly)

$ 1.14

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	11-07-2023	09-30-2023	10-Q
2	08-08-2023	06-30-2023	10-Q
3	05-09-2023	03-31-2023	10-Q
4	03-29-2023	12-31-2022	10-K
5	11-07-2022	09-30-2022	10-Q
6	08-04-2022	06-30-2022	10-Q
7	05-09-2022	03-31-2022	10-Q
8	03-04-2022	12-31-2021	10-K
9	11-05-2021	09-30-2021	10-Q
10	08-09-2021	06-30-2021	10-Q
11	05-05-2021	03-31-2021	10-Q
12	02-23-2021	12-31-2020	10-K
13	11-04-2020	09-30-2020	10-Q
14	08-05-2020	06-30-2020	10-Q
15	05-11-2020	03-31-2020	10-Q
16	02-18-2020	12-31-2019	10-K
17	10-31-2019	09-30-2019	10-Q
18	08-01-2019	06-30-2019	10-Q
19	05-03-2019	03-31-2019	10-Q
20	02-21-2019	12-31-2018	10-K
21	11-01-2018	09-30-2018	10-Q
22	08-02-2018	06-30-2018	10-Q
23	05-02-2018	03-31-2018	10-Q
24	02-21-2018	12-31-2017	10-K
25	11-01-2017	09-30-2017	10-Q
26	08-02-2017	06-30-2017	10-Q
27	05-03-2017	03-31-2017	10-Q
28	02-22-2017	12-31-2016	10-K
29	11-02-2016	09-30-2016	10-Q
30	08-03-2016	06-30-2016	10-Q
31	05-04-2016	03-31-2016	10-Q
32	02-25-2016	12-31-2015	10-K
33	11-05-2015	09-30-2015	10-Q
34	08-07-2015	06-30-2015	10-Q
35	05-06-2015	03-31-2015	10-Q
36	02-25-2015	12-31-2014	10-K
37	11-12-2014	09-30-2014	10-Q
38	08-12-2014	06-30-2014	10-Q
39	05-13-2014	03-31-2014	10-Q
40	03-05-2014	12-31-2013	10-K

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

bluebird bio Recieves Receipt Of Delinquen...
08/23/2024 20:07:11

bluebird bio, Inc. (NASDAQ:BLUE) today announced that it received notices (the "notices") on August 20, 2024 from The N...

What 4 Analyst Ratings Have To Say About b...
08/15/2024 20:02:29

B of A Securities Maintains Buy on bluebir...
08/15/2024 17:17:35

B of A Securities analyst Jason Gerberry maintains bluebird bio (NASDAQ:BLUE) with a Buy and lowers the price target from $4...

RBC Capital Reiterates Sector Perform on b...
08/15/2024 14:53:46

RBC Capital analyst Luca Issi reiterates bluebird bio (NASDAQ:BLUE) with a Sector Perform and maintains $4 price target.

Barclays Maintains Overweight on bluebird ...
08/15/2024 13:52:49

Barclays analyst Gena Wang maintains bluebird bio (NASDAQ:BLUE) with a Overweight and lowers the price target from $8 to $4.

this-snowflake-analyst-is-no-longer-bullish-here-are-top-5-downgrades-for-thursday

This Snowflake Analyst Is No Longer Bullis...
08/15/2024 12:29:01

Baird Maintains Outperform on bluebird bio...
08/15/2024 10:58:37

Baird analyst Jack Allen maintains bluebird bio (NASDAQ:BLUE) with a Outperform and lowers the price target from $7 to $6.

JP Morgan Downgrades bluebird bio to Neutral
08/15/2024 10:54:12

JP Morgan analyst Eric Joseph downgrades bluebird bio (NASDAQ:BLUE) from Overweight to Neutral.

bluebird bio Q2 Sales $16.100M Beat $10.66...
08/14/2024 11:03:07

bluebird bio Says Continuing To Work Exped...
05/29/2024 11:09:43

On March 26, 2024, bluebird announced that it will restate its consolidated financial statements for the first three quarters a...

bluebird bio Names James Sterling As CFO, ...
05/29/2024 11:07:59

Sterling most recently served as chief financial officer of Renalytix plc, a diagnostics company focused on clinical management...

10-health-care-stocks-with-whale-alerts-in-todays-session

10 Health Care Stocks With Whale Alerts In...
05/09/2024 17:35:23

bluebird bio Q1 Sales $18.600M Miss $19.55...
05/09/2024 11:01:12

bluebird bio (NASDAQ:BLUE) reported quarterly sales of $18.600 million which missed the analyst consensus estimate of $19.551 m...

Bluebird Bio Announces Receipt Of Expected...
04/26/2024 20:06:35

bluebird bio, Inc. (NASDAQ:BLUE) today announced that it received a notice (the "notice") on April 24, 2024 from The Na...

Bluebird Bio Inc Anticipates It Will Be De...
04/16/2024 20:26:47

- SEC Filing

Watching Bluebird Bio; Shares Spike Higher...
04/15/2024 20:17:16

Peeling Back The Layers: Exploring bluebir...
03/27/2024 16:01:11

RBC Capital Reiterates Sector Perform on b...
03/27/2024 15:36:43

RBC Capital analyst Luca Issi reiterates bluebird bio (NASDAQ:BLUE) with a Sector Perform and maintains $6 price target.

Wells Fargo Maintains Equal-Weight on blue...
03/27/2024 12:34:50

Wells Fargo analyst Yanan Zhu maintains bluebird bio (NASDAQ:BLUE) with a Equal-Weight and lowers the price target from $4 t...

12-health-care-stocks-moving-in-tuesdays-pre-market-session

12 Health Care Stocks Moving In Tuesday's ...
03/26/2024 13:05:52